Topical Application of the Synthetic Triterpenoid RTA 408 Protects Mice from Radiation-Induced Dermatitis
April 2014
in “
Radiation Research
”
Studysummary This study observed that topically applied RTA 408 reduced the severity of radiation-induced dermatitis in mice, with the highest dose significantly reducing and alleviating skin damage and associated inflammation.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study evaluated the protective effects of RTA 408, a synthetic triterpenoid, against radiation-induced dermatitis in mice. Mice were irradiated and treated with varying concentrations of RTA 408, which significantly reduced dermatitis severity in a dose-dependent manner. The highest concentration (1.0%) led to normal skin appearance, substantial hair regrowth, and alleviation of skin ulcers by day 40. These effects were linked to increased expression of antioxidative Nrf2 target genes and decreased expression of proinflammatory NF-κB target genes, suggesting RTA 408 as a promising therapy for radiation-induced dermatitis.
